2026-01-02 - Analysis Report
Here's an analysis of Schrodinger Inc. (SDGR) based on the provided data.

**0) Report Overview**

This report provides an analysis of Schrodinger Inc. (SDGR), comparing its performance against the S&P 500 (VOO) and examining various financial and market indicators to assess its investment potential.

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.
*   **Cumulative Return Comparison:**
    *   SDGR Cumulative Return: -55.41%
    *   VOO (S&P 500) Cumulative Return: 69.47%
    *   Divergence: -124.88 (Relative Divergence: 1.3)

*   **Analysis of Divergence:** SDGR has significantly underperformed the S&P 500. The negative divergence highlights this disparity, indicating that the stock has fallen considerably compared to the market benchmark. The relative divergence of 1.3 suggests the current divergence is near the bottom end of its historical range.

*   **Alpha, Beta & Risk Analysis (2021-2025):**
    *   **CAGR:** Consistently negative CAGR values indicate poor returns over the analyzed periods.
    *   **MDD:** High Maximum Drawdown (MDD) suggests significant volatility and potential for substantial losses.
    *   **Alpha:** Large negative Alpha figures imply the stock has underperformed relative to its expected return based on its beta.
    *   **Beta:** High Beta values indicate the stock is more volatile than the market.
    *   **Cap(B):** The listed numbers do not provide a clear conclusion with current data.

*   **Summary:** The provided alpha/beta analysis reveals high volatility, negative returns, and underperformance relative to the market. These factors suggest a higher level of risk associated with investing in SDGR during the analyzed periods.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** \$17.88
*   **Previous Close:** \$17.80
*   **Change:** +0.45
*   **5-day SMA:** \$18.04
*   **20-day SMA:** \$18.01
*   **60-day SMA:** \$18.81

*   **Analysis:** The current price is slightly above the previous close, indicating a minor increase. The 5-day and 20-day Simple Moving Averages (SMA) are close, suggesting short-term price stability. The 60-day SMA is higher, indicating a slightly declining trend in the medium term.

**3) RSI, PPO & Hybrid Signal Analysis**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 49.43
*   **PPO:** 0.18
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change:** -0.4 (Short-term decline)
*   **Expected Return:** 0.0%

*   **Analysis:**
    *   **MRI:** Despite the company's poor financial performance, the high MRI suggests the model is indicating strong upside potential. This could be related to future catalysts, industry tailwinds, or other factors not immediately apparent in the financial data. This warrants further investigation.
    *   **RSI:** The RSI of 49.43 is neutral, indicating neither overbought nor oversold conditions.
    *   **PPO:** The positive PPO suggests a possible uptrend, but its value is small.
    *   **Hybrid Signal:** The signal indicates a "Buy" recommendation, suggesting the model believes the stock is undervalued based on the MRI.
    *   **Divergence Change:** The recent negative divergence change indicates a short-term downward trend relative to the comparison stock.
    *   **Expected Return:** 0.0% suggests limited expected excess return compared to the S&P 500.

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   "Unlocking Hidden Value In Schrodinger's Box" (Seeking Alpha)
    *   "Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now" (Yahoo Finance, Nasdaq)
    *   "New Analyst Forecast: \$SDGR Given \$24 Price Target" (Quiver Quantitative)
    *   "Schrodinger, Inc. \$SDGR Shares Purchased by Nikko Asset Management Americas Inc." (MarketBeat)
    *   "Morgan Stanley Assumes Coverage on Schr√∂dinger (SDGR) Stock" (Yahoo Finance)

*   **Analysis:** Recent news presents a mixed picture. Some articles suggest the stock is a "Buy the Bottom" opportunity and highlight potential hidden value. An analyst forecast indicates a price target of \$24. However, the purchase of shares by Nikko Asset Management Americas Inc., and the new coverage by Morgan Stanley might reflect due diligence rather than outright bullish sentiment.

**4-2) Analyst Opinions**

*   **Consensus:** No meaningful key value for the analyst consensus.
*   **Opinions:** 9
*   **Target Price:** Average: \$27.22, High: \$33.00, Low: \$18.00

*   **Analysis:** The analyst target price range suggests potential upside, with the average target significantly higher than the current price. This indicates analysts believe the stock is undervalued.

**5) Recent Earnings Analysis**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2025-11-05 | -0.45 | \$0.05B       |
| 2025-08-06 | -0.59 | \$0.05B       |
| 2025-05-07 | -0.82 | \$0.06B       |
| 2024-11-12 | -0.52 | \$0.04B       |
| 2025-11-05 | -0.52 | \$0.04B       |

*   **Analysis:** The company has consistently reported negative EPS, indicating a lack of profitability. Revenue has fluctuated but remained relatively stable.

**6) Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | \$0.05B   | 51.61%       |
| 2025-06-30   | \$0.05B   | 47.77%       |
| 2025-03-31   | \$0.06B   | 52.26%       |
| 2024-12-31   | \$0.09B   | 72.61%       |
| 2024-09-30   | \$0.04B   | 50.24%       |

*   **Analysis:** Profit margins are relatively high, suggesting strong pricing power. However, high profitability does not translate to profits.

*   **Capital and Profitability:**

| Quarter      | Equity   | ROE        |
|--------------|----------|------------|
| 2025-09-30   | \$0.32B   | -10.21%    |
| 2025-06-30   | \$0.34B   | -12.59%    |
| 2025-03-31   | \$0.37B   | -16.01%    |
| 2024-12-31   | \$0.42B   | -9.54%     |
| 2024-09-30   | \$0.45B   | -8.49%     |

*   **Analysis:** Equity has been decreasing, and the negative Return on Equity (ROE) reflects the company's inability to generate profits from its equity.

**7) Comprehensive Analysis (Summary)**

*   **Performance:** SDGR has significantly underperformed the S&P 500, with negative cumulative returns and high volatility.

*   **Financial Health:** The company is currently unprofitable, as indicated by negative EPS and ROE. Revenue is relatively stable, and profit margins are high, but these have not been sufficient to achieve profitability. Equity has been decreasing.

*   **Market Sentiment:** Recent news articles suggest potential upside and hidden value, with analysts setting higher target prices. However, the high MRI conflicts with the poor financial performance.

*   **Investment Recommendation:** The data presents a mixed signal. While recent news and analyst targets point to potential upside, the company's poor financial performance, high volatility, and underperformance compared to the S&P 500 are concerning. The high MRI suggests potential and warrants further exploration, but **caution is advised.** This investment would be considered high-risk and speculative. Investors should conduct further due diligence and carefully consider their risk tolerance before investing.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.